About
Monitoring Cancer Treatment Efficacy
Curesign is a medical device company aiming to disrupt the way oncologists treat patients with cancer. The companys solution is based on the integration of sensors with advanced signal-processing and big data tools. Curesigns product, which is in the advanced stages of development, is designed to allow clinical teams to tailor a patient-specific treatment for each cancer patient. Curesigns technology has been successfully demonstrated in preclinical studies. Based on the results, the company is currently working on a commercial product for use in many preclinical trials in the field of oncology.
Identity
| Name | CureSign |
|---|---|
| Slug | curesign |
| Type / kind | startup |
| Crunchbase ID | curesign-ltd |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LW15IsLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Feb 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Magshimim |
| HQ address | Magshimim, Israel |
Web & social
| https://www.linkedin.com/company/64934511 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcareMedical Decision Support
Technologies
SensingArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
big-datacancer-therapycancermedical-devicesoncologysensorssignal-processing
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}